FindTrial
Sign In

Effects of esketamine on postoperative anxiety and depression in patients with painless abortion

Effects of esketamine on postoperative anxiety and depression in patients with painless abortion

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200067206
Enrollment
Unknown
Registered
2022-12-29
Start date
2023-01-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative anxiety and depression in patients with painless abortion

Interventions

Group K:Intravenous application of esketamine for anesthesia in patients with painless abortion
Group S:Intravenous sufentanil for anesthesia in patients with painless abortion

Sponsors

Beijing Huaxin Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 30 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-30 years; 2. ASA Level 1-2; 3. Patients planning to undergo induced abortion for the first time.

Exclusion criteria

Exclusion criteria: 1. Patients with a diagnosed mental illness; 2. Suspicious difficult airway; 3. Heart disease; 4. Patients who need to change the anesthesia method due to various accidents; 5. Unable or unwilling to provide informed consent or poor compliance.

Design outcomes

Primary

MeasureTime frame
anxiety self-rating scale;self-rating depression scale;visual analogue scale score;—

Countries

China

Contacts

Public ContactZhang Dongya

Beijing Huaxin Hospital

13911150451@139.com+86 13911150451

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026